Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathlyn Stone

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Annals of Neurology|March 10, 2011
NerveCenter: What imaging method is best for stroke?Kathlyn Stone
Annals of Neurology|October 30, 2010
NerveCenter: Unintended effects of biologic drug market protectionKathlyn Stone
Annals of Neurology|June 18, 2011
Who controls the price of pharmaceuticals?Kathlyn Stone
Annals of Neurology|July 26, 2011
NerveCenter: messages from the brain at restKathlyn Stone
Annals of Neurology|September 10, 2011
Richard Olney's perspective as physician-scientist and patientKathlyn Stone
Annals of Neurology|December 23, 2011
Will federal budget policies have long-term repercussions for neurology research?Kathlyn Stone
Annals of Neurology|December 14, 2011
NerveCenter: Are federal laboratory regulations a double-edged sword?Kathlyn Stone
Annals of Neurology|June 18, 2011
Japan's neurological community contends with triple disasterKathlyn Stone
Annals of Neurology|March 28, 2012
Medical device conflict of interest in the CCSVI debateKathlyn Stone
Annals of Neurology|March 30, 2011
NerveCenter: Debate heats up over NIH realignment plansKathlyn Stone
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Annals of Neurology|March 10, 2011
NerveCenter: What imaging method is best for stroke?Kathlyn Stone
Annals of Neurology|October 30, 2010
NerveCenter: Unintended effects of biologic drug market protectionKathlyn Stone
Annals of Neurology|June 18, 2011
Who controls the price of pharmaceuticals?Kathlyn Stone
Annals of Neurology|July 26, 2011
NerveCenter: messages from the brain at restKathlyn Stone
Annals of Neurology|September 10, 2011
Richard Olney's perspective as physician-scientist and patientKathlyn Stone
Annals of Neurology|December 23, 2011
Will federal budget policies have long-term repercussions for neurology research?Kathlyn Stone
Annals of Neurology|December 14, 2011
NerveCenter: Are federal laboratory regulations a double-edged sword?Kathlyn Stone
Annals of Neurology|June 18, 2011
Japan's neurological community contends with triple disasterKathlyn Stone
Annals of Neurology|March 28, 2012
Medical device conflict of interest in the CCSVI debateKathlyn Stone
Annals of Neurology|March 30, 2011
NerveCenter: Debate heats up over NIH realignment plansKathlyn Stone
Pageof 3